The chronic autoimmune conditions — both considered types of inflammatory bowel disease — cause a myriad of symptoms ...

A genetics‑guided drug, compound 6, targets CARD9 to subtly calm gut inflammation in Crohn’s disease, pointing to safer, longer‑lasting, precision treatments.

New research shows that Rytvela, an anti-inflammatory drug candidate, decreased premature birth and infant mortality when ...

Nine people with a rare genetic condition that causes life-threatening inflammatory reactions appear to have been cured, after taking part in the first trial of a new version of a CRISPR-based gene ...

Dr. Yoshiteru Shimoide, immunologist and director of the Yoshiteru Shimoide Internal Medicine Clinic in Kagoshima, Japan, has developed RO‑8, the world’s first therapeutic agent designed to ...

Studies suggest that ginger possesses anti-inflammatory properties attributable to its unique chemical properties. Regular intake may offer pain relief benefits for people with inflammatory disorders.

Ultimately, effective treatment selection integrates rigorous evaluation of evidence with individualized discussions of safety, efficacy, convenience, and patient values. By tailoring therapy to ...

Chronic inflammation is both a driver and suppressor of cancer depending on context. Key players-NF-κB, IL-6, STAT3, TAMs, MDSCs, and Tregs-orchestrate a tumor-permissive microenvironment.

Learn the difference between induction and maintenance phases in ANCA-associated vasculitis (AAV) treatment, including what to expect from medications like rituximab (Rituxan).

Heidi Lobprise, DVM, DAVDC, explains how chronic, low-level inflammation drives aging and disease in dogs.